Glioblastoma Clinical Trials in Chicago, IL

Glioblastoma Clinical Trials in Chicago, IL

View the best 10 glioblastoma medical studies in Chicago, Illinois. Access promising new therapies by applying to a Chicago-based Glioblastoma clinical trial.

Top rated glioblastoma clinical trials in Chicago, Illinois

Here are the top 10 medical studies for glioblastoma in Chicago, Illinois

Image of Children's Hospital of Alabama in Birmingham, United States.

Larotrectinib

Kinase Inhibitor

Recruiting1 awardPhase 2
This trial is testing larotrectinib, which may stop the growth of cancer cells, in patients with solid tumors, non-Hodgkin lymphoma, or histiocytic disorders that have spread and come back or do not respond to treatment.
Image of Children's Hospital Los Angeles in Los Angeles, United States.

APX005M

Monoclonal Antibodies

Recruiting1 awardPhase 1
This trial studies the side effects and best dose of APX005M in treating younger patients with primary malignant central nervous system tumor.
Image of Grandview Cancer Center in Birmingham, United States.

OptuneĀ®

Device

Recruiting1 award12 criteria
This trial is testing a new treatment for brain cancer that combines Optune with radiation and chemotherapy. The goal is to see if this new combination is more effective and has fewer side effects than current treatments.
Image of Children's Hospital of Alabama in Birmingham, United States.

Olaparib

PARP Inhibitor

Recruiting1 awardPhase 2
This trial is testing how well olaparib works in treating patients with solid tumors, non-Hodgkin lymphoma, or histiocytic disorders with defects in DNA damage repair genes.
Image of Northwestern University in Evanston, United States.

Clindamycin Phosphate

Recruiting1 awardPhase 2
This trial will test whether using clindamycin and triamcinolone topical lotions can prevent skin-related side effects for people being treated with Tumor Treating Fields for malignant glioma.
Image of Sarah Cannon Research Institute in Denver, United States.

ST101

Virus Therapy

Recruiting1 awardPhase 1 & 2
This trial is testing a new cancer drug to see if it is safe and effective.
Image of Littleton Adventist Hospital in Littleton, United States.

Lomustine +2 More

Alkylating agents

Recruiting2 awardsPhase 3
This trial is comparing the effect of adding lomustine to temozolomide and radiation therapy versus temozolomide and radiation therapy alone in treating newly diagnosed MGMT methylated glioblastoma.
Image of Kaiser Permanente Los Angeles Medical Center in Los Angeles, United States.

Ramipril

ACE Inhibitor

Recruiting1 awardPhase 2
This trial is testing whether Ramipril can help cancer patients undergoing chemoradiation treatment by reducing memory loss. Patients will take the drug throughout treatment and for four months after. Memory will be assessed using neurocognitive tests.
Image of Saint Joseph's Hospital and Medical Center in Phoenix, United States.

Bevacizumab

Monoclonal Antibodies

Recruiting1 award
This trial uses DSC-MRI to measure rCBV to determine response to bevacizumab in patients with recurrent glioblastoma. DSC-MRI may help to evaluate changes in cancer blood vessels.
Image of University of Alabama at Birmingham in Birmingham, United States.

VAL-083 +7 More

Alkylating agents

Recruiting1 awardPhase 2 & 3
This trial is designed to test multiple therapies for glioblastoma, a type of brain cancer.

Popular filter options for glioblastoma chicago trials

Clinical Trials With No Placebo

View 41 medical studies that do not have a placebo group.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' ā€” so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back ā€” in general, verified trials respond to patients within a few days.